Clinical Study of UCB Combined With UC-MSCs in the Treatment of Bone Marrow Failure Disorders

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

April 30, 2025

Study Completion Date

April 30, 2026

Conditions
Bone Marrow Failure Disorders
Interventions
DRUG

Cyclosporine A

3-5 mg per kilogram per day.

BIOLOGICAL

Umbilical cord blood & Umbilical cord derived mesenchymal stem cells

Intravenous infusion of umbilical cord blood and umbilical cord derived mesenchymal stem cells (5-8×10\^7) at 1 week interval.

Trial Locations (8)

250031

RECRUITING

Shandong Provincial Third Hospital, Jinan

Unknown

RECRUITING

Rizhao People's Hospital, Rizhao

RECRUITING

Tai'an Central Hospital, Tai’an

RECRUITING

Weihai Municipal Hospital, Weihai

RECRUITING

Yantai Ludong Hospital (Shandong Provincial Hospital Group), Yantai

RECRUITING

Affiliated Hospital of Shandong University of Traditional Chinese Medicine, Jinan

RECRUITING

Jining first people's Hospital, Jining

RECRUITING

Linyi People's Hospital, Linyi

All Listed Sponsors
collaborator

Shandong Province Third hospital

OTHER

collaborator

Dezhou People's Hospital

OTHER

collaborator

Children's Hospital Affiliated to Shandong University

UNKNOWN

collaborator

The Second Affiliated Hospital of Shandong First Medical University

OTHER

collaborator

Tai'an Central Hospital

UNKNOWN

collaborator

Linyi People's Hospital

OTHER

collaborator

Rizhao People's Hospital

OTHER

collaborator

Lanling People's Hospital

UNKNOWN

collaborator

Jining First People's Hospital

OTHER

collaborator

Jining Medical University

OTHER

collaborator

Zibo Municipal Hospital

OTHER

collaborator

Binzhou People's Hospital

OTHER

collaborator

The Affiliated Hospital of Binzhou Medical College

UNKNOWN

collaborator

Shengli Oilfield Hospital

OTHER

collaborator

Weihai Municipal Hospital

OTHER

collaborator

Weihai Central Hospital

OTHER

collaborator

Shandong University of Traditional Chinese Medicine

OTHER

collaborator

Gansu Provincial Hospital of Traditional Chinese Medicine (TCM)

UNKNOWN

collaborator

Wuwei People's Hospital

UNKNOWN

collaborator

Gansu Wuwei Tumor Hospital

OTHER

collaborator

The Second Affiliated Hospital of Harbin Medical University

OTHER

collaborator

Yuncheng Institute of Hematology

UNKNOWN

collaborator

Kaifeng Central Hospital

OTHER

collaborator

Zhengzhou Central Hospital

OTHER

collaborator

Air Force Hospital of Western War Zone

UNKNOWN

collaborator

The First People' s Hospital of Yunnan Province

UNKNOWN

collaborator

Zigong No.1 Peoples Hospital

OTHER

collaborator

The First People's Hospital of Jingzhou

OTHER

collaborator

Jiangxi Province Children's Hospital

OTHER

collaborator

Second Affiliated Hospital of Zhengzhou University

OTHER

collaborator

Yantai Ludong Hospital (Shandong Provincial Hospital Group)

UNKNOWN

lead

Shandong Qilu Stem Cells Engineering Co., Ltd.

INDUSTRY